Current evidence suggests that GLP-1 medications, when used with appropriate patient selection and monitoring, likely do not pose significant long-term threats to vision for most patients and may contribute to better overall ocular outcomes through improved metabolic control
The GLP-1 receptor component slows gastric emptying so you feel full longer and eat less, an effect Cleveland Clinic describes in its overview of how GLP-1 medications act on appetite and blood sugar
Malyszczak A, Przezdziecka-Dolyk J, Szydelko-Pasko U, Misiuk-Hojlo M
Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Analyst Opinion at Fact.MR Shambhu Nath Jha, Sr